ACS Middle Atlantic Regional Meeting
April 10-13, 2010
American Chemical Society (ACS)
Finnegan attorney Christine Hlavka will present “Requirements for Patentability: Utility, Novelty, Nonobvious, Enablement, and Written Description,” Krista Bianco will present “What Constitutes an Invention: Conception, Reduction to Practice, and Inventorship” and “A Patent Litigation Primer,” Maureen Queler will present “Best Practices in Drafting and Prosecuting a Patent Application,” and Justin Hasford will present “Overview of ANDA Pharmaceutical Patent Litigation in the United States” as part of the "What a Chemist Needs to Know About Patent Law" program at the American Chemical Society Mid-Atlantic Regional Meeting. Casey Dwyer will present “Omission Without Intent is Not Inequitable Conduct: AstraZeneca Pharmaceuticals LP v. Teva Pharmaceuticals USA, Inc. (Fed. Cir. 2009),” Shana Cyr will present “In re ‘318 Patent Litigation : The Enablement and Utility Requirements,” Sheetal Patel will present “Implications of Wyeth v. Kappos,” and Mary Chlebowski will present Product-by-Process: What You Say Is What You Get,” as part of the "Recent Update in Patent Law" lecture. The program will take place at the Hotel Du Pont in Wilmington, Delaware. For more information, or to register, please see ACS’s website.